Biotechnology Merry Christmas and a Happy New Year European Biotechnology wishes its readers a Merry Christmas and a Happy New Year! We are taking a short winter break and will be back in January 2025 to provide you with the latest news, background reports, personalia and – in cooperation with our new partner, the Society for Laboratory Automation & Screening (SLAS) – updates […] Written by Thomas Gabrielczyk December 26, 2024December 26, 2024 Saving Bookmark this article Bookmarked
Pollinators most vulnerable to rising global temperatures are flies, study shows Despite their reputation as buzzing nuisances, flies serve a critical role as some of the Earth’s most prolific pollinators — and new research led by Penn State scientists suggests they are increasingly at risk due to rising global temperatures. In a study recently published in the Journal of Melittology, an international team of researchers looked […] Written by Admin December 25, 2024December 25, 2024 Saving Bookmark this article Bookmarked
U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome Copenhagen, Denmark, December 19, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that… Written by Admin December 25, 2024December 25, 2024 Saving Bookmark this article Bookmarked
Pollinators most vulnerable to rising global temperatures are flies, study shows Despite their reputation as buzzing nuisances, flies serve a critical role as some of the Earth’s most prolific pollinators — and new research led by Penn State scientists suggests they are increasingly at risk due to rising global temperatures. In a study recently published in the Journal of Melittology, an international team of researchers looked […] Written by Admin December 25, 2024December 25, 2024 Saving Bookmark this article Bookmarked
U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome Copenhagen, Denmark, December 19, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that… Written by Admin December 25, 2024December 25, 2024 Saving Bookmark this article Bookmarked
Functionally conserved inner mitochondrial membrane proteins CCDC51 and Mdm33 demarcate a subset of fission events While extensive work has examined the mechanisms of mitochondrial fission, it remains unclear whether internal mitochondrial proteins in metazoans play a direct role in the process. Previously, the yeast inner membrane protein Mdm33 was shown to be required for normal mitochondrial morphology and has been hypothesized to be involved in mitochondrial fission. However, it is […] Written by Admin December 25, 2024December 25, 2024 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked
